Preaxia Health Care Payment Systems (PAXH) Price to Sales (2021 - 2023)

Preaxia Health Care Payment Systems has disclosed Price to Sales across 3 years of filings, most recently posting 43928.22 for Q1 2023.

• In Q1 2023, Price to Sales rose 1293.33% year-over-year to 43928.22; the TTM figure through Feb 2023 stood at 43928.22 (up 1293.33% YoY), while the FY2022 annual figure was 5371.66, down 6.93% from the prior year.
• Price to Sales came in at 43928.22 for Q1 2023 at Preaxia Health Care Payment Systems, up from 12227.44 in the prior quarter.
• In the past five years, Price to Sales ranged from a high of 118606.19 in Q1 2021 to a low of 2608.64 in Q4 2021.
• Average Price to Sales over 3 years is 22405.3, with a median of 5771.59 recorded in 2021.
• Year-over-year, Price to Sales tumbled 97.34% in 2022 and surged 1293.33% in 2023.
• Over 3 years, Price to Sales stood at 2608.64 in 2021, then jumped by 368.73% to 12227.44 in 2022, then jumped by 259.26% to 43928.22 in 2023.
• Per Business Quant data, the three most recent Price to Sales figures were 43928.22 in Q1 2023, 12227.44 in Q4 2022, and 6045.17 in Q3 2022.